» Articles » PMID: 39659849

Optimization of Concentrations and Exposure Durations of Commonly Used Positive Controls in the in Vitro Alkaline Comet Assay

Overview
Date 2024 Dec 11
PMID 39659849
Authors
Affiliations
Soon will be listed here.
Abstract

Endogenous and exogenous factors cause DNA damage through chemical changes in the genomic DNA structure. The comet assay is a versatile, rapid, and sensitive method for evaluating DNA integrity at the individual cell level. It is used in human biomonitoring studies, the identification of DNA lesions, and the measurement of DNA repair capacity. Despite its widespread application, variations between studies remain problematic, often due to the lack of a common protocol and appropriate test controls. Using positive controls is essential to assess inter-experimental variability and ensure reliable results. Hydrogen peroxide (HO) is the most commonly used positive control, while potassium bromate (KBrO₃), methyl methanesulfonate (MMS), ethyl methanesulfonate (EMS), -ethyl--nitrosourea (ENU), and etoposide are used less frequently. However, differences in concentrations and exposure durations prevent the confirmation of test method efficacy. This study investigates the dose-response relationship for HO, KBrO, MMS, EMS, ENU and etoposide in the comet assay for 30 and 60-minute exposure durations in 3T3 cell lines. Accordingly recommended concentrations and exposure durations were found to be 50 μM 30 minutes (HO); 500 μM 60 min. (MMS); 10 μM 30 min. (Etoposide); 0.2 mM 30 min. and 2 mM 60 min. (EMS); 2 mM 30 min. (ENU); 500 μM 30 min. and 50 μM 60 min. (KBrO). Our findings will contribute to reducing inter-laboratory variability by offering guidance on selecting doses and exposure durations for positive controls in the alkaline comet assay.

References
1.
Moller P, Moller L, Godschalk R, Jones G . Assessment and reduction of comet assay variation in relation to DNA damage: studies from the European Comet Assay Validation Group. Mutagenesis. 2010; 25(2):109-11. DOI: 10.1093/mutage/gep067. View

2.
Petersen E, Nguyen A, Brown J, Elliott J, Clippinger A, Gordon J . Characteristics to consider when selecting a positive control material for an in vitro assay. ALTEX. 2021; 38(2):365-376. DOI: 10.14573/altex.2102111. View

3.
Parsons J, Chipman J . The role of glutathione in DNA damage by potassium bromate in vitro. Mutagenesis. 2000; 15(4):311-6. DOI: 10.1093/mutage/15.4.311. View

4.
Esteves F, Amaro R, Silva S, Sanchez-Flores M, Teixeira J, Costa C . The impact of comet assay data normalization in human biomonitoring studies outcomes. Toxicol Lett. 2020; 332:56-64. DOI: 10.1016/j.toxlet.2020.06.024. View

5.
Ersson C, Moller P, Forchhammer L, Loft S, Azqueta A, Godschalk R . An ECVAG inter-laboratory validation study of the comet assay: inter-laboratory and intra-laboratory variations of DNA strand breaks and FPG-sensitive sites in human mononuclear cells. Mutagenesis. 2013; 28(3):279-86. DOI: 10.1093/mutage/get001. View